Biomerica, Inc. (BMRA)
2.23
-0.11
(-4.70%)
USD |
NASDAQ |
Sep 09, 14:02
Biomerica Max Drawdown (5Y) : 98.34% for Aug. 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| August 31, 2026 | 98.34% |
| July 31, 2026 | 98.34% |
| June 30, 2026 | 98.34% |
| May 31, 2026 | 98.34% |
| April 30, 2026 | 98.34% |
| March 31, 2026 | 98.34% |
| February 28, 2026 | 98.34% |
| January 31, 2026 | 98.34% |
| December 31, 2025 | 98.34% |
| November 30, 2025 | 98.34% |
| October 31, 2025 | 98.34% |
| September 30, 2025 | 98.34% |
| August 31, 2025 | 98.34% |
| July 31, 2025 | 98.34% |
| June 30, 2025 | 98.34% |
| May 31, 2025 | 98.34% |
| April 30, 2025 | 98.34% |
| March 31, 2025 | 98.34% |
| February 28, 2025 | 98.34% |
| January 31, 2025 | 98.34% |
| December 31, 2024 | 98.34% |
| November 30, 2024 | 98.28% |
| October 31, 2024 | 98.28% |
| September 30, 2024 | 98.28% |
| August 31, 2024 | 98.28% |
| Date | Value |
|---|---|
| July 31, 2024 | 97.94% |
| June 30, 2024 | 97.38% |
| May 31, 2024 | 96.67% |
| April 30, 2024 | 96.67% |
| March 31, 2024 | 95.56% |
| February 29, 2024 | 95.56% |
| January 31, 2024 | 95.56% |
| December 31, 2023 | 95.56% |
| November 30, 2023 | 95.56% |
| October 31, 2023 | 95.56% |
| September 30, 2023 | 94.88% |
| August 31, 2023 | 93.19% |
| July 31, 2023 | 93.00% |
| June 30, 2023 | 93.00% |
| May 31, 2023 | 93.00% |
| April 30, 2023 | 92.25% |
| March 31, 2023 | 88.38% |
| February 28, 2023 | 83.69% |
| January 31, 2023 | 83.69% |
| December 31, 2022 | 83.69% |
| November 30, 2022 | 83.69% |
| October 31, 2022 | 83.69% |
| September 30, 2022 | 83.69% |
| August 31, 2022 | 83.69% |
| July 31, 2022 | 83.69% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Abbott Laboratories | 39.63% |
| Align Technology, Inc. | 82.89% |
| AngioDynamics, Inc. | 82.98% |
| Accuray, Inc. | 96.17% |
| Alphatec Holdings, Inc. | 73.51% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -50.45 |
| Beta (5Y) | 0.3721 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 77.60% |
| Historical Sharpe Ratio (5Y) | -0.6067 |
| Historical Sortino (5Y) | -1.368 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 30.76% |